The Cancer Letter

The leading source for information on the issues that shape oncology since 1973

Guest Editorial

How Delaware became a model for improving cancer control, prevention, and treatment

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print
BYLINE
IN THIS ISSUE
BYLINEDOWNLOAD PDFTABLE OF CONTENTS

As I step down as medical director of the Helen F. Graham Cancer Center and Research Institute (HFGCCRI) at Christiana Care later this year and assume the position of director of the Cawley Center for Translational Cancer Research at the HFGCCRI, I can reflect back on the success of cancer care in Delaware.

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Byline
Nicholas J. Petrelli, MD
Bank of America Endowed Medical Director, Helen F. Graham Cancer Center and Research Institute, ChristianaCare Health System; Associate director of translational research, Wistar Cancer Institute
Table of Contents

YOU MAY BE INTERESTED IN

PodcastThe Directors

The Directors: Directors of two Midwestern cancer centers tell us about the challenging healthcare economics in rural areas
“Institutions are feeling crunched in so many different directions”

How’s this for a paradox: The better cancer centers become at keeping patients alive, the more expensive cancer care becomes. This brutal tradeoff hits harder in rural areas, where the cancer burden is higher and the investigator and clinical trial representation is lower.
By Paul Goldberg and Claire Marie Porter

Eric Small, ASCO’s immediate past president, speaks on the toll of toxicity—financial, emotional, physical—in cancer
“Discovery alone is not enough. It’s about what becomes of what we discover. It’s about translation.”

In a poignant keynote punctuated with anecdotes about grief, American Society of Clinical Oncology’s immediate past president Eric Small emphasized that the annual conference is not just about scientific discovery, but about a responsibility to translate discoveries into better outcomes for cancer patients globally. 
By Claire Marie Porter
Cancer History ProjectPodcast

“Backwater to Blockbuster” chronicles the previously untold story of the explosive growth of St. Jude Children’s Research Hospital
In a conversation with Deborah Doroshow, co-authors Chuck Sherr and Bill Evans discuss their collaborative writing process

“Backwater to Blockbuster,” the first de novo book published by the Cancer History Project, traces the evolution of St. Jude Children’s Research Hospital to its current status of a powerhouse of research in pediatric cancer.
By Claire Marie Porter
Byline
Nicholas J. Petrelli, MD
Bank of America Endowed Medical Director, Helen F. Graham Cancer Center and Research Institute, ChristianaCare Health System; Associate director of translational research, Wistar Cancer Institute
Table of Contents

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login

Site license subscribers:
Log in with your IP | Register a sponsored account